From grafa.com

BioCryst initiates Phase 1 trial enrolment for Netherton syndrome therapy

1 1

BioCryst Pharmaceuticals <a href='https://grafa.com/asset/biocryst-pharmaceuticals-inc-11605-bcrx.nasdaq'>(NASDAQ:BCRX)</a> has announced the enrollment of t

#News #grafa #nasdaq #pharmaceuticals

6h ago

From grafa.com

The Hydration Pharmaceuticals to sell non-US assets for US$9.5M

1 1

The Hydration Pharmaceuticals <a href='https://grafa.com/asset/hydration-pharmaceuticals-company-ltd-7590-hpc.asx'>(ASX:HPC)</a>, known as 'Hydralyte US,' ha

#asx #News #business #ecommerce #pharmaceuticals

13h ago